Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea
· Delayed Price · Currency is KRW 13,140
-130 (-0.98%)
Jun 5, 2025, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 156.32 billion as of June 6, 2025.
Market Cap
156.32B
Enterprise Value
139.74B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,140.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 156.32B, an increase of 47.13%. That is a compound annual growth rate of 130.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 156.32B | 107.93% |
| Dec 30, 2024 | 75.18B | -29.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.53T |
| Celltrion | 34.68T |
| ALTEOGEN | 19.69T |
| Yuhan | 7,778.15B |
| SK Biopharmaceuticals | 7,079.52B |
| HLB Co., Ltd. | 6,860.00B |
| PharmaResearch | 4,976.64B |
| LigaChem Biosciences | 3,893.48B |